NCT03230669

Brief Summary

Computer-based Training for Cognitive Behavioural Therapy (CBT4CBT) is a new on-line addiction treatment developed by Dr Kathleen Carroll at the Yale School of Medicine in New Haven, Connecticut. CBT4CBT consists of seven one-hour long online sessions that teach key concepts, including dealing with cravings, problem solving, and decision making skills, to help users reduce substance abuse. CBT4CBT has been rigorously tested throughout various communities in the United States with great success and is currently being rolled out throughout the States. The therapeutic approach of CBT4CBT is unique as its efficacy, durability and cost-savings have been proven in several rigorous clinical trials and will be magnified by the fact that the program can be delivered in Canada, allowing for increased and continual improvements in population health. CBT4CBT has been accepted by both patients and addiction treatment personnel alike and has won numerous clinical innovation awards. A collaboration has now been formed between Dr Carroll and Drs Michelle Patterson and Juergen Krause of the UPEI Centre for Health and Community Research (CHCR) that will bring CBT4CBT to Canada. While CBT4CBT has previously been tested in urban areas, there are many advantages to offering computer-based training to more rural populations (such as PEI). These more remote areas frequently suffer from a lack of services, as well as a lack of continuity with the services currently offered. CBT4CBT may very well provide that needed continuity to Addictions treatment and has also been shown to improve retention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 26, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

2.2 years

First QC Date

July 20, 2017

Last Update Submit

May 4, 2021

Conditions

Keywords

substance abuseaddictionetherapy

Outcome Measures

Primary Outcomes (1)

  • primary substance use

    Substance use of individuals of their primary drug (or drug of choice)

    6 months

Secondary Outcomes (3)

  • Secondary substance use

    6 months

  • Healthcare, social and justice interaction

    6 months

  • CBT4CBT feedback

    8 weeks

Study Arms (2)

Control

NO INTERVENTION

this arm receives treatment as usual and no intervention.

CBT4CBT

EXPERIMENTAL

This arm receives treatment as usual and in addition are given access to an online therapy, cbt4cbt. If placed in this group, individuals are asked to use the online therapy for a minimum of 30 minutes each week for the trial duration of 8 weeks.

Other: cbt4cbt

Interventions

cbt4cbtOTHER

This arm receives treatment as usual and in addition are given access to an online therapy, cbt4cbt. If placed in this group, individuals are asked to use the online therapy for a minimum of 30 minutes each week for the trial duration of 8 weeks.

CBT4CBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who are struggling with substance abuse (the definition of 'abuse' is determined by their counselor).
  • Individuals who are 18 years of age or older
  • Individuals who have used their substance of choice within the past 28 days.

You may not qualify if:

  • Individuals who are currently suicidal, homicidal, or require immediate hospitalization will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Prince Edward Island

Charlottetown, Prince Edward Island, C1A 4P3, Canada

Location

MeSH Terms

Conditions

Substance-Related DisordersBehavior, Addictive

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersCompulsive BehaviorImpulsive BehaviorBehavior

Study Officials

  • Juergen Krause, phd

    University of Prince Edward Island

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project Coordinator

Study Record Dates

First Submitted

July 20, 2017

First Posted

July 26, 2017

Study Start

January 1, 2016

Primary Completion

March 31, 2018

Study Completion

December 31, 2018

Last Updated

May 7, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations